Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of UDP-G1cNAc:Ga1.beta.1-3Ga1NAc.alpha.R .beta.1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes

Inhibitors of UDP-G1cNAc:Ga1.beta.1-3Ga1NAc.alpha.R .beta.1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes

US Patent 6131578 · Granted Oct 17, 2000

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Robotic process automation system with separate code loading2024
Zero footprint robotic process automation system2024
Robotic process automation using virtual machine and programming language interp2023
Robotic process automation system with a command action logic independent execut2023
Zero footprint robotic process automation system2023
Robotic process automation system with device user impersonation2023
Vehicle infotainment system2022
Robotic process automation system with quality of service based automation2022
Robotic process automation system with a command action logic independent execut2022
Platform agnostic robotic process automation2022
Robotic process automation system with separate platform, bot and command class 2021
Analogs of N-acetlyglucosamine and uses thereof2021